Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Randomized, 4-Way Crossover Study to Evaluate the Effect of Varying Bonding Strength Between Active and Inactive Layers on Adhesion of the Corplex Donepezil Transdermal Delivery System in Healthy Volunteers

Next Previous
Trial Profile

A Phase 1, Randomized, 4-Way Crossover Study to Evaluate the Effect of Varying Bonding Strength Between Active and Inactive Layers on Adhesion of the Corplex Donepezil Transdermal Delivery System in Healthy Volunteers

Status: Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 04 Jun 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease; Dementia
  • Focus Adverse reactions
  • Sponsors Corium International

Most Recent Events

  • 03 Jun 2021 Status changed from not yet recruiting to withdrawn prior to enrolment.
  • 23 Apr 2020 Planned End Date changed from 10 Jul 2020 to 14 Sep 2020.
  • 23 Apr 2020 Planned initiation date changed from 11 May 2020 to 26 Jun 2020.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top